Enhancing competition in on-patent markets:
The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among off-patent medicines, but generally do not induce c...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Paris
OECD Publishing
2023
|
| Schriftenreihe: | OECD Health Working Papers
no.156 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among off-patent medicines, but generally do not induce competition in on-patent markets. While tendering is widely used for hospital and other institutional purchasing, it is less common for ambulatory care medicines, or where medicines are reimbursed rather than supplied directly. As part of its broader work agenda on "Increasing the transparency of pharmaceutical markets to inform policies", this paper explores how payers could harness competition to improve the efficiency of spending on medicines still subject to patent protection or regulatory exclusivity. The OECD undertook an extensive analysis consisting of two parts: 1) a quantitative analysis using product-level time series sales data to explore whether therapeutic competition occurs, and, if so, how it has affected prices and volumes over time, based on a sample of countries and therapeutic classes and 2) a review of current practices and policies on pricing, coverage and procurement of on-patent medicines to identify whether these have been influencing competition between alternative therapeutic products. This report presents the key findings from this analytical work. |
| Beschreibung: | 1 Online-Ressource (80 p.) 21 x 28cm. |
| DOI: | 10.1787/413f2820-en |
Internformat
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | ZDB-13-SOC-095320067 | ||
| 003 | DE-627-1 | ||
| 005 | 20231204121311.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230810s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1787/413f2820-en |2 doi | |
| 035 | |a (DE-627-1)095320067 | ||
| 035 | |a (DE-599)KEP095320067 | ||
| 035 | |a (FR-PaOEC)413f2820-en | ||
| 035 | |a (EBP)095320067 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barrenho, Eliana |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Enhancing competition in on-patent markets |c Eliana, Barrenho ... [et al] |
| 264 | 1 | |a Paris |b OECD Publishing |c 2023 | |
| 300 | |a 1 Online-Ressource (80 p.) |c 21 x 28cm. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a OECD Health Working Papers |v no.156 | |
| 520 | |a The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among off-patent medicines, but generally do not induce competition in on-patent markets. While tendering is widely used for hospital and other institutional purchasing, it is less common for ambulatory care medicines, or where medicines are reimbursed rather than supplied directly. As part of its broader work agenda on "Increasing the transparency of pharmaceutical markets to inform policies", this paper explores how payers could harness competition to improve the efficiency of spending on medicines still subject to patent protection or regulatory exclusivity. The OECD undertook an extensive analysis consisting of two parts: 1) a quantitative analysis using product-level time series sales data to explore whether therapeutic competition occurs, and, if so, how it has affected prices and volumes over time, based on a sample of countries and therapeutic classes and 2) a review of current practices and policies on pricing, coverage and procurement of on-patent medicines to identify whether these have been influencing competition between alternative therapeutic products. This report presents the key findings from this analytical work. | ||
| 650 | 4 | |a Social Issues/Migration/Health | |
| 700 | 1 | |a Moens, Marjolijn |e MitwirkendeR |4 ctb | |
| 700 | 1 | |a Waagstein, Lisbeth |e MitwirkendeR |4 ctb | |
| 700 | 1 | |a Lopert, Ruth |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/413f2820-en |3 Volltext |
| 912 | |a ZDB-13-SOC | ||
| 951 | |a BO | ||
| 912 | |a ZDB-13-SOC | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-13-SOC-095320067 |
|---|---|
| _version_ | 1816797313913323520 |
| adam_text | |
| any_adam_object | |
| author | Barrenho, Eliana |
| author2 | Moens, Marjolijn Waagstein, Lisbeth Lopert, Ruth |
| author2_role | ctb ctb ctb |
| author2_variant | m m mm l w lw r l rl |
| author_facet | Barrenho, Eliana Moens, Marjolijn Waagstein, Lisbeth Lopert, Ruth |
| author_role | aut |
| author_sort | Barrenho, Eliana |
| author_variant | e b eb |
| building | Verbundindex |
| bvnumber | localFWS |
| collection | ZDB-13-SOC |
| ctrlnum | (DE-627-1)095320067 (DE-599)KEP095320067 (FR-PaOEC)413f2820-en (EBP)095320067 |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1787/413f2820-en |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02551cam a22003612 4500</leader><controlfield tag="001">ZDB-13-SOC-095320067</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121311.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230810s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/413f2820-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)095320067</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP095320067</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)413f2820-en</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)095320067</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Barrenho, Eliana</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enhancing competition in on-patent markets</subfield><subfield code="c">Eliana, Barrenho ... [et al]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (80 p.)</subfield><subfield code="c">21 x 28cm.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Health Working Papers</subfield><subfield code="v">no.156</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among off-patent medicines, but generally do not induce competition in on-patent markets. While tendering is widely used for hospital and other institutional purchasing, it is less common for ambulatory care medicines, or where medicines are reimbursed rather than supplied directly. As part of its broader work agenda on "Increasing the transparency of pharmaceutical markets to inform policies", this paper explores how payers could harness competition to improve the efficiency of spending on medicines still subject to patent protection or regulatory exclusivity. The OECD undertook an extensive analysis consisting of two parts: 1) a quantitative analysis using product-level time series sales data to explore whether therapeutic competition occurs, and, if so, how it has affected prices and volumes over time, based on a sample of countries and therapeutic classes and 2) a review of current practices and policies on pricing, coverage and procurement of on-patent medicines to identify whether these have been influencing competition between alternative therapeutic products. This report presents the key findings from this analytical work.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moens, Marjolijn</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Waagstein, Lisbeth</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopert, Ruth</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/413f2820-en</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-13-SOC-095320067 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-26T14:55:36Z |
| institution | BVB |
| language | English |
| open_access_boolean | |
| owner | DE-863 DE-BY-FWS |
| owner_facet | DE-863 DE-BY-FWS |
| physical | 1 Online-Ressource (80 p.) 21 x 28cm. |
| psigel | ZDB-13-SOC |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | OECD Publishing |
| record_format | marc |
| series2 | OECD Health Working Papers |
| spelling | Barrenho, Eliana VerfasserIn aut Enhancing competition in on-patent markets Eliana, Barrenho ... [et al] Paris OECD Publishing 2023 1 Online-Ressource (80 p.) 21 x 28cm. Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Health Working Papers no.156 The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among off-patent medicines, but generally do not induce competition in on-patent markets. While tendering is widely used for hospital and other institutional purchasing, it is less common for ambulatory care medicines, or where medicines are reimbursed rather than supplied directly. As part of its broader work agenda on "Increasing the transparency of pharmaceutical markets to inform policies", this paper explores how payers could harness competition to improve the efficiency of spending on medicines still subject to patent protection or regulatory exclusivity. The OECD undertook an extensive analysis consisting of two parts: 1) a quantitative analysis using product-level time series sales data to explore whether therapeutic competition occurs, and, if so, how it has affected prices and volumes over time, based on a sample of countries and therapeutic classes and 2) a review of current practices and policies on pricing, coverage and procurement of on-patent medicines to identify whether these have been influencing competition between alternative therapeutic products. This report presents the key findings from this analytical work. Social Issues/Migration/Health Moens, Marjolijn MitwirkendeR ctb Waagstein, Lisbeth MitwirkendeR ctb Lopert, Ruth MitwirkendeR ctb FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/413f2820-en Volltext |
| spellingShingle | Barrenho, Eliana Enhancing competition in on-patent markets Social Issues/Migration/Health |
| title | Enhancing competition in on-patent markets |
| title_auth | Enhancing competition in on-patent markets |
| title_exact_search | Enhancing competition in on-patent markets |
| title_full | Enhancing competition in on-patent markets Eliana, Barrenho ... [et al] |
| title_fullStr | Enhancing competition in on-patent markets Eliana, Barrenho ... [et al] |
| title_full_unstemmed | Enhancing competition in on-patent markets Eliana, Barrenho ... [et al] |
| title_short | Enhancing competition in on-patent markets |
| title_sort | enhancing competition in on patent markets |
| topic | Social Issues/Migration/Health |
| topic_facet | Social Issues/Migration/Health |
| url | https://doi.org/10.1787/413f2820-en |
| work_keys_str_mv | AT barrenhoeliana enhancingcompetitioninonpatentmarkets AT moensmarjolijn enhancingcompetitioninonpatentmarkets AT waagsteinlisbeth enhancingcompetitioninonpatentmarkets AT lopertruth enhancingcompetitioninonpatentmarkets |